INL-4

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameINL-4
Drug Alias NameINL-4
ClassificationOther
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInnolife Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInnolife Co Ltd
Inactive CompaniesN/A
Active IndicationsAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A